What bisam pharma does

Bisam Pharma is a privately held Indian pharmaceutical company headquartered in Hyderabad that operates across two integrated business lines: manufacturing and consulting. On the manufacturing side, it produces generic medicines, Active Pharmaceutical Ingredients (APIs) and intermediates, and offers contract manufacturing services. On the consulting side, it provides regulatory consulting (covering submissions, audits, and compliance across USFDA, EMA, MHRA, TGA, and SAHPRA), clinical research consultancy (early-phase trials, BA/BE studies, IND submissions), and drug development consulting (strategy, CMC, toxicology, GMP compliance) across molecules, biologics, and devices.

The company holds ISO 9001:2008 certification and claims 26+ years of collective pharmaceutical industry experience, though no specific founding personnel, headcount, or technical platform details are disclosed. Its stated technology base consists of state-of-the-art R&D and production facilities designed to meet global standards, with no proprietary software, AI, or digital platform components described in the source material.

Bisam Pharma serves biotech, pharmaceutical, and medical device companies across regulated and emerging markets through a B2B enterprise sales motion. Pricing is quote-based and not publicly disclosed, with a 'Get a Quote' call-to-action on its website. The company claims a global market footprint with strong presence in exports, generic formulations, and ethical products, though no named customers, revenue figures, funding rounds, distribution agreements, or geographic offices outside Hyderabad are evidenced. No management team, investors, patents, or material M&A activity are disclosed, indicating a small, privately controlled operation with limited externally verifiable scale signals.

Name

bisam pharma

Legal name

Bisam Pharma

Website

https://bisampharma.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Bisam Pharma is a privately held Hyderabad-based pharmaceutical company that manufactures generics, APIs, and contract-manufactured products while providing regulatory, clinical research, and drug development consulting to biotech, pharma, and medical device companies across global regulated markets.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic APIs & Intermediates (Active Ingredients) (HLAIABAG)

akta.pro secondary industries

Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Generic pharmaceuticals
• Active pharmaceutical ingredients
• Contract manufacturing
• Regulatory consulting
• Clinical research services

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Regulatory Consulting Services: Consulting fees for regulatory submissions, audits, and compliance services across USFDA, EMA, MHRA, TGA, SAHPRA and other regulatory bodies.
2. Clinical Research Consultancy: End-to-end clinical trial support services including early-phase trials, BA/BE studies, and IND submissions.
3. Drug Development Consulting: Comprehensive lab-to-launch expertise covering strategy, CMC, toxicology, and GMP compliance.
4. Generics Products: Sale of high-quality generic medicines across multiple therapeutic areas.
5. APIs & Intermediates: Manufacturing and sale of Active Pharmaceutical Ingredients and intermediates meeting global regulatory standards.
6. Contract Manufacturing: Flexible, scalable manufacturing solutions with end-to-end support in R&D, production, and quality assurance.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

Bisam Pharma manufactures and sells generic medicines and APIs/intermediates, provides contract manufacturing services for third parties, and delivers regulatory, clinical research, and drug development consulting services to pharmaceutical, biotech, and medical device companies. The company operates under ISO 9001:2008 certified quality systems from its Hyderabad, India base.

Product overview

Bisam Pharma offers a comprehensive pharmaceutical portfolio consisting of three core product lines (Generics, APIs & Intermediates, and Contract Manufacturing) alongside three consulting services (Regulatory Consulting, Clinical Research Consultancy, and Drug Development Consulting). The company operates as a unified pharma partner providing end-to-end solutions from lab to launch, combining manufacturing capabilities with regulatory and clinical expertise to serve biotech, pharma, and medical device companies across regulated and emerging markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Generic Medicines Finished generic pharmaceutical formulations manufactured and sold by Bisam Pharma for regulated international markets.
• APIs and Intermediates Active pharmaceutical ingredients and chemical intermediates supplied to other pharmaceutical manufacturers for use in drug formulations.
• Contract Manufacturing Services Third-party manufacturing of pharmaceutical products under ISO 9001:2008 certified quality systems for clients lacking in-house capacity.
• Regulatory Consulting Services Consulting support for regulatory filings and submissions across USFDA, EMA, MHRA, TGA, and SAHPRA jurisdictions.
• Clinical Research Consultancy Clinical research consulting services supporting pharmaceutical and biotech clients in clinical development activities.
• Drug Development Consulting Consulting services for drug development programs supporting pharmaceutical and biotech clients.

Quantifiable outcome

• Faster market access through right-first-time regulatory submissions
• +1 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered minor.

• Doctor Plus AIminorOthersPartner company with logo displayed on Bisam Pharma website. Doctor Plus AI appears to be a healthcare/medical technology company offering AI-powered doctor services. Nature of partnership not explicitly detailed.
• Amruth Swasth BharathminorOthersPartner company with logo displayed on Bisam Pharma website. Amruth Swasth Bharath appears to be an Indian healthcare initiative. Nature of partnership not explicitly detailed.
• Quick VitalsminorOthersPartner company with logo displayed on Bisam Pharma website. Quick Vitals appears to be a health monitoring/vitals technology company. Nature of partnership not explicitly detailed.
• Farmers APPminorOthersPartner company with logo displayed on Bisam Pharma website. Farmers APP appears to be an agricultural services platform under bisamconsulting.com.au. Nature of partnership not explicitly detailed.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Sai Life Sciences: India-based integrated CRO-CDMO offering drug discovery, CMC, API development, and clinical research services. Closely comparable to Bisam across both the regulatory/clinical consulting and API/intermediates manufacturing verticals.
• Neuland Laboratories: India-based pure-play API manufacturer with USFDA-inspected facilities and CRO/CDMO offerings. Directly comparable to Bisam on generic API/intermediates manufacturing and regulatory submission support.
• Syngene International: India's largest publicly listed CRO offering discovery, development, and manufacturing services across small molecules and biologics. Overlaps with Bisam's lab-to-launch consulting and contract manufacturing mix.

Broad incumbents

• Piramal Pharma Solutions: Large global CDMO offering API manufacturing, drug product, and biologics services with significant scale and broader geographic footprint than Bisam; comparable on contract manufacturing and CMC services.
• Aurobindo Pharma: One of India's largest generic API and finished dosage manufacturers with extensive USFDA approvals. Comparable to Bisam on generic APIs and finished generics, though at vastly greater scale.
• IQVIA: Global leader in clinical research, regulatory, and consulting services for pharma and biotech. Comparable to Bisam across clinical research consultancy and regulatory consulting service lines.
• Syneos Health: Global CRO providing clinical development, regulatory, and commercial services to pharma/biotech. Comparable to Bisam on clinical research consultancy and regulatory submissions service mix.

Regional players

• Morepen Laboratories: Indian API manufacturer specializing in generic APIs and intermediates with export focus. Directly comparable to Bisam on APIs/intermediates manufacturing and export-led business model.
• Divis Laboratories: India-based API and intermediates manufacturer with strong USFDA inspection history and custom synthesis services. Comparable to Bisam on generic APIs/intermediates manufacturing and global regulatory positioning.
• Optimus Pharma: India-based generic finished formulations and API manufacturer offering contract manufacturing services. Comparable to Bisam on integrated generics + APIs + contract manufacturing model at similar sub-scale tier.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/bisam-pharma

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about bisam pharma